chalcone has been researched along with 4'-methoxychalcone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Batt, DG; Covington, MB; Goodman, R; Jones, DG; Kerr, JS; Mantegna, LR; McAllister, C; Newton, RC; Nurnberg, S; Welch, PK | 1 |
| Gilmore, JM; Hill, RR; Hoong, LK; Hotema, MR; Kunsch, C; Marino, EM; Meng, CQ; Ni, L; Sikorski, JA; Simpson, JE; Skudlarek, JW; Suen, KL; Wasserman, MA; Weingarten, MD; Worsencroft, KJ; Ye, Z; Zheng, XS | 1 |
| Biswal, S; Hassan, M; Kumar, A; Kumar, S; Kumar, V; Malhotra, SV; Parmar, VS; Sharma, SK; Thimmulappa, RK; Wu, H | 1 |
| Iwai, A; Kim, YS; Kumar, V; Lee, S; Malhotra, SV; Neckers, L; Trepel, JB | 1 |
| Kumar, J; Padaria, JC; Sathiyendiran, M; Shakil, NA; Singh, MK | 1 |
| Bracke, ME; De Ryck, T; Katritzky, AR; Patronov, A; Roman, BI; Slavov, SH; Stevens, CV; Vanhoecke, BW | 1 |
| Abdullah, M; Bilal, A; Chotana, GA; Emwas, AH; Faisal, A; Gao, X; Iftikhar, S; Khan, S; Manzoor, S; Saleem, RSZ; Sioud, S | 1 |
| Aguilar, AM; Andrade, CKZ; Baldim, JL; da Costa-Silva, TA; Gomes, KS; Lago, JHG; Melo, LR; Oliveira, IH; Oliveira-Silva, D; Silva, WA; Tempone, AG; Uemi, M | 1 |
| Binda, C; Bortolini, B; Christodoulou, MS; Dalla Via, L; Di Paolo, ML; Facchetti, G; Iacovino, LG; Passarella, D; Pinzi, L; Rastelli, G; Rimoldi, I | 1 |
| Chapman, E; Chitre, S; Doud, EH; Georgiadis, MM; Johnson, SM; Liechty, H; O'Hagan, HM; Ray, AM; Sivinski, J; Stevens, M; Tepper, K; Washburn, A | 1 |
| Wattenberg, L | 1 |
1 review(s) available for chalcone and 4'-methoxychalcone
| Article | Year |
|---|---|
Chalcones, myo-inositol and other novel inhibitors of pulmonary carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Chalcone; Chalcones; Dexamethasone; Female; Inositol; Lung Neoplasms; Mice; Mice, Inbred A; Plant Oils | 1995 |
10 other study(ies) available for chalcone and 4'-methoxychalcone
| Article | Year |
|---|---|
2'-substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis.
Topics: Animals; Cell Survival; Chalcone; Female; Humans; Interleukin-1; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Monocytes; Shock, Septic; Structure-Activity Relationship | 1993 |
Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression.
Topics: Chalcone; Heterocyclic Compounds; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2004 |
Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells.
Topics: Animals; Bronchi; Cell Line; Cell Survival; Chalcones; Enzyme Activators; Epithelial Cells; Glutamate-Cysteine Ligase; Heme Oxygenase-1; Humans; Male; Mice; Mice, Inbred C57BL; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidation-Reduction; Quantitative Structure-Activity Relationship; Reactive Oxygen Species; Stereoisomerism; Transcription, Genetic | 2011 |
Methoxychalcone inhibitors of androgen receptor translocation and function.
Topics: Androgen Antagonists; Cell Line, Tumor; Chalcones; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Male; Prostatic Neoplasms; Protein Transport; Receptors, Androgen | 2012 |
Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Chalcones; Cyclohexanones; Indazoles; Inhibitory Concentration 50; Klebsiella pneumoniae; Magnetic Resonance Spectroscopy; Microwaves; Molecular Structure; Rhizoctonia | 2013 |
4-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent. From discovery to initial validation in an in vivo metastasis model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Products; Cell Line, Tumor; Cell Movement; Cell Survival; Chalcones; Chick Embryo; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Female; Humans; Mice; Mice, Nude; Molecular Structure; Myocardium; Neoplasm Invasiveness; Neoplasm Metastasis; Quantitative Structure-Activity Relationship | 2015 |
Synthesis and evaluation of modified chalcone based p53 stabilizing agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcone; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Molecular Structure; Protein Stability; Structure-Activity Relationship; Tumor Suppressor Protein p53 | 2017 |
Structure-activity relationship study of antitrypanosomal chalcone derivatives using multivariate analysis.
Topics: Animals; Chalcones; Multivariate Analysis; Structure-Activity Relationship; Trypanosoma cruzi | 2019 |
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
Topics: | 2021 |
Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
Topics: | 2022 |